Skip to main content

Drug-Resistant Gonorrhea May Get A New Antibiotic

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 3, 2023.

By Physician’s Briefing Staff HealthDay Reporter

FRIDAY, Nov. 3, 2023 -- The first new antibiotic for gonorrhea -- the second most common sexually transmitted disease -- has shown promise in a clinical trial.

This new antibiotic, called zoliflodacin, was seen in the trial to cure uncomplicated gonorrhea infection as effectively as the current go-to treatment -- ceftriaxone along with one dose of azithromycin pills.

The drug was developed by U.S.-based Innoviva Specialty Therapeutics and Swiss nonprofit Global Antibiotic Research & Development Partnership.

"The outcome of this study is a potential game changer for sexual health," Edward Hook III, M.D., protocol chair for the study and emeritus professor of medicine at the University of Alabama in Birmingham, said in a news release from the drug's developers. "In addition to the potential benefits for patients with infections with resistant strains of Neisseria gonorrhoeae, the potential lack of cross-resistance with other antibiotics and the oral route of administration will simplify gonorrhea therapy for clinicians worldwide."

Zoliflodacin treats gonorrhea in a new way. However, it is less effective at treating gonorrhea infection of the throat than it is in the genital or rectal areas, NBC News reported.

Innoviva said it expects to seek U.S. Food and Drug Administration approval "as quickly as practicably possible."

NBC News Article

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted November 2023

Read this next

Only Half of Adults Believe They Should Disclose Sexually Transmitted Infection Status

FRIDAY, June 7, 2024 -- Only half of individuals disclose or believe they should disclose having a sexually transmitted infection (STI) prior to sexual intercourse, according to a...

CDC Recommends Doxycycline PEP for Gay Men, Transgender Women

WEDNESDAY, June 5, 2024 -- In clinical guidelines issued by the U.S. Centers for Disease Control and Prevention and published June 4 in the agency's Morbidity and Mortality Weekly...

Recommended Treatment for STIs More Likely in Public Versus Private Health Care Settings

TUESDAY, April 30, 2024 -- Individuals seen for sexually transmitted infections (STIs) by clinicians in a private U.S. health care setting are less likely to receive recommended...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.